CSPC Pharmaceutical Group Limited (HKG:1093)

CSPC Pharmaceutical Group Revenue

CSPC Pharmaceutical Group had revenue of 12.13B CNY in the quarter ending June 30, 2026, with 93.80% growth. This brings the company's total for the last twelve months to 31.33B, up 20.50% year-over-year. In the year 2025, CSPC Pharmaceutical Group had annual revenue of 26.01B, down -10.35%. That makes CSPC Pharmaceutical Group the 2,777th largest company in the world by revenue and 184th in Hong Kong.

• Revenue (ttm): 31.33B CNY
• Revenue Growth: +20.50%
• P/S Ratio: 2.75
• Revenue / Employee: 1.68M CNY
• Employees: 18,626
• Market Cap: 95.10B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Nervous System 7.82B 30.1%
• Anti-Infectives 3.32B 12.8%
• Vitamin C 2.23B 8.6%
• Oncology 2.20B 8.5%
• Cardiovascular 1.83B 7.1%
• License Fee Income 1.79B 6.9%
• Functional Food and Others 1.77B 6.8%
• Other 5.05B 19.4%

By Geography

Chart

• Mainland China 20.83B 80.1%
• Europe 2.43B 9.3%
• Other Asian Regions 1.26B 4.9%
• North America 890.21M 3.4%
• Other Geographies 596.27M 2.3%

Fiscal year ended Dec 31, 2025 See the full CSPC Pharmaceutical Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.01B	-3.00B	-10.35%
Dec 31, 2024	29.01B	-2.44B	-7.76%
Dec 31, 2023	31.45B	513.21M	1.66%
Dec 31, 2022	30.94B	3.07B	11.02%
Dec 31, 2021	27.87B	2.92B	11.73%

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Sep 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error